Semaglutide is a medication that was originally developed to treat type 2 diabetes. However, in recent years, it has been studied for its potential use in promoting weight loss. In fact, a higher dose of semaglutide has been approved by the FDA as a weight loss medication under the brand name Wegovy.

Semaglutide works by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1), which is produced in the gut and helps regulate appetite and glucose metabolism. By activating GLP-1 receptors in the brain, semaglutide can help to reduce feelings of hunger and increase feelings of fullness.

Clinical trials have shown that semaglutide can lead to significant weight loss in people who are overweight or obese when used in conjunction with diet and exercise. In one trial, participants who took semaglutide lost an average of 15% of their body weight over a 68-week period.

However, it’s important to note that semaglutide is not a magic bullet for weight loss. It is still necessary to make lifestyle changes, such as adopting a healthy diet and engaging in regular physical activity, in order to achieve sustainable weight loss. Additionally, semaglutide may not be suitable for everyone, and it can have side effects such as nausea, diarrhea, and constipation. It’s important to discuss any potential medication use with your healthcare provider.